Preparation, Characterization, and In Vivo Evaluation of an Oral Multiple Nanoemulsive System for Co-Delivery of Pemetrexed and Quercetin

Co-administration of conventional and natural chemotherapeutics offers synergistic anticancer efficacy while minimizing adverse effects. In this study, an oral co-delivery system for pemetrexed (PMX) and quercetin (QCN) was designed based on water-in-oil-in-water nanoemulsion (NE), which is highly absorbable because it enhances the intestinal membrane permeability of PMX and aqueous solubility of QCN. To create this system, an ion-pairing complex of PMX with Nα-deoxycholyl-l-lysyl-methylester (DCK) was formed and further incorporated with QCN into the NE, yielding PMX/DCK-QCN-NE. The results revealed synergistic inhibitory effects on human lung carcinoma (A549) cell proliferation and migration after combined treatment with PMX/DCK and QCN. The intestinal membrane permeability and cellular uptake of PMX/DCK and QCN from the NE were significantly improved via facilitated transport of PMX by the interaction of DCK with bile acid transporters, as well as NE formulation-mediated alterations in the membrane structure and fluidity, which resulted in 4.51- and 23.9-fold greater oral bioavailability of PMX and QCN, respectively, than each free drug. Tumor growth in A549 cell-bearing mice was also maximally suppressed by 62.7% after daily oral administration of PMX/DCK-QCN-NE compared with controls. Thus, PMX/DCK-QCN-NE is a promising oral nanocarrier of PMX and QCN for synergistic anticancer efficacy and long-term chemotherapy.

[1]  Xun Sun,et al.  Enhanced antitumor and anti‐metastasis efficacy against aggressive breast cancer with a fibronectin‐targeting liposomal doxorubicin , 2018, Journal of controlled release : official journal of the Controlled Release Society.

[2]  Yan Yang,et al.  Modified mixed nanomicelles with collagen peptides enhanced oral absorption of Cucurbitacin B: preparation and evaluation , 2018, Drug delivery.

[3]  L. Xin,et al.  Evaluation of METase-pemetrexed-loaded PEG–PLGA nanoparticles modified with anti-CD133–scFV for treatment of gastric carcinoma , 2017, Bioscience reports.

[4]  M. Keidar,et al.  Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery , 2017, International journal of nanomedicine.

[5]  Si-Won Kang,et al.  Oral delivery of quercetin in oil-in-water nanoemulsion: In vitro characterization and in vivo anti-obesity efficacy in mice , 2017 .

[6]  G. Flamini,et al.  Butylated Hydroxytoluene (BHT) emitted by fungi naturally occurring in olives during their pre-processing storage for improving olive oil stability , 2017 .

[7]  Y. Liu,et al.  Application of a lipid-coated hollow calcium phosphate nanoparticle in synergistic co-delivery of doxorubicin and paclitaxel for the treatment of human lung cancer A549 cells , 2017, International journal of nanomedicine.

[8]  Q. Wang,et al.  Formulation of water-in-oil-in-water (W/O/W) emulsions containing trans -resveratrol , 2017 .

[9]  D. Spandidos,et al.  Anticancer and apoptosis-inducing effects of quercetin in vitro and in vivo , 2017, Oncology reports.

[10]  Yitao Wang,et al.  Co-delivery of paclitaxel and tetrandrine via iRGD peptide conjugated lipid-polymer hybrid nanoparticles overcome multidrug resistance in cancer cells , 2017, Scientific Reports.

[11]  Q. Wang,et al.  Enhanced oral bioavailability of quercetin by a new non‐aqueous self‐double‐emulsifying drug delivery system , 2017 .

[12]  D. Grzanka,et al.  Antiproliferative and antimetastatic action of quercetin on A549 non-small cell lung cancer cells through its effect on the cytoskeleton. , 2017, Acta histochemica.

[13]  Patrick J Faustino,et al.  Pharmaceutical characterization of novel tenofovir liposomal formulations for enhanced oral drug delivery: in vitro pharmaceutics and Caco-2 permeability investigations , 2017, Clinical pharmacology : advances and applications.

[14]  C. Luceri,et al.  Nanoemulsion for improving solubility and permeability of Vitex agnus-castus extract: formulation and in vitro evaluation using PAMPA and Caco-2 approaches , 2017, Drug delivery.

[15]  A. Demiroglu-Zergeroglu,et al.  Quercetin and Cisplatin combined treatment altered cell cycle and mitogen activated protein kinase expressions in malignant mesotelioma cells , 2016, BMC Complementary and Alternative Medicine.

[16]  T. Webster,et al.  A solid self-nanoemulsifying system of the BCS class IIb drug dabigatran etexilate to improve oral bioavailability. , 2016, Nanomedicine.

[17]  F. Cardoso,et al.  Oral chemotherapy in advanced breast cancer: expert perspectives on its role in clinical practice , 2016 .

[18]  Mahesh Hegde,et al.  Quercetin, a Natural Flavonoid Interacts with DNA, Arrests Cell Cycle and Causes Tumor Regression by Activating Mitochondrial Pathway of Apoptosis , 2016, Scientific Reports.

[19]  S. Srivastava,et al.  Nanoemulsion formulations for anti-cancer agent piplartine--Characterization, toxicological, pharmacokinetics and efficacy studies. , 2016, International journal of pharmaceutics.

[20]  Y. Byun,et al.  Oral delivery of zoledronic acid by non-covalent conjugation with lysine-deoxycholic acid: In vitro characterization and in vivo anti-osteoporotic efficacy in ovariectomized rats. , 2016, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[21]  Ashish Ranjan Sharma,et al.  Application of Bioactive Quercetin in Oncotherapy: From Nutrition to Nanomedicine , 2016, Molecules.

[22]  A. Saxena,et al.  Pharmacokinetics, dose proportionality and permeability of S002-333 and its enantiomers, a potent antithrombotic agent, in rabbits , 2015, Xenobiotica; the fate of foreign compounds in biological systems.

[23]  D. S. Lee,et al.  Absorption Mechanism of a Physical Complex of Monomeric Insulin and Deoxycholyl-l-lysyl-methylester in the Small Intestine. , 2015, Molecular pharmaceutics.

[24]  A. Khuda-Bukhsh,et al.  Quercetin Down-regulates IL-6/STAT-3 Signals to Induce Mitochondrial-mediated Apoptosis in a Nonsmall- cell Lung-cancer Cell Line, A549 , 2015, Journal of pharmacopuncture.

[25]  Chuanbin Wu,et al.  Enhancing oral bioavailability of quercetin using novel soluplus polymeric micelles , 2014, Nanoscale Research Letters.

[26]  F. Shakeel,et al.  Double w/o/w nanoemulsion of 5-fluorouracil for self-nanoemulsifying drug delivery system , 2014 .

[27]  K. Yoon,et al.  Enhanced apoptosis by pemetrexed and simvastatin in malignant mesothelioma and lung cancer cells by reactive oxygen species-dependent mitochondrial dysfunction and Bim induction. , 2014, International journal of oncology.

[28]  R. Korpela,et al.  Deoxycholic acid induced changes in electrophysiological parameters and macromolecular permeability in murine small intestine with and without functional enteric nervous system plexuses , 2014, Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society.

[29]  F. Liu,et al.  Combinational Delivery of Hydrophobic and Hydrophilic Anticancer Drugs in Single Nanoemulsions To Treat MDR in Cancer , 2014, Molecular pharmaceutics.

[30]  L. Dong,et al.  Enhanced bioavailability of poorly absorbed hydrophilic compounds through drug complex/in situ gelling formulation. , 2013, International journal of pharmaceutics.

[31]  Rahul P Gangwal,et al.  Oral delivery of anticancer drugs: challenges and opportunities. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[32]  Y. Oh,et al.  Development of docetaxel-loaded solid self-nanoemulsifying drug delivery system (SNEDDS) for enhanced chemotherapeutic effect. , 2013, International journal of pharmaceutics.

[33]  Amit Jain,et al.  Co-encapsulation of tamoxifen and quercetin in polymeric nanoparticles: implications on oral bioavailability, antitumor efficacy, and drug-induced toxicity. , 2013, Molecular pharmaceutics.

[34]  Y. Byun,et al.  Enhanced oral absorption of ibandronate via complex formation with bile acid derivative. , 2013, Journal of pharmaceutical sciences.

[35]  K. Sak.  Chemotherapy and Dietary Phytochemical Agents , 2012, Chemotherapy research and practice.

[36]  Munirah Ahmad,et al.  Quercetin-induced inhibition and synergistic activity with cisplatin – a chemotherapeutic strategy for nasopharyngeal carcinoma cells , 2012, Cancer Cell International.

[37]  P. Beale,et al.  Synergism from combinations of cisplatin and oxaliplatin with quercetin and thymoquinone in human ovarian tumour models. , 2011, Anticancer research.

[38]  Guangjun Nie,et al.  Enhanced anti-tumor efficacy by co-delivery of doxorubicin and paclitaxel with amphiphilic methoxy PEG-PLGA copolymer nanoparticles. , 2011, Biomaterials.

[39]  Michael J Zaworotko,et al.  Cocrystals of quercetin with improved solubility and oral bioavailability. , 2011, Molecular pharmaceutics.

[40]  C. Chen,et al.  Quercetin: a potential drug to reverse multidrug resistance. , 2010, Life sciences.

[41]  Li Yang,et al.  Co-delivery of doxorubicin and plasmid by a novel FGFR-mediated cationic liposome. , 2010, International journal of pharmaceutics.

[42]  Mushir M. Ali,et al.  Study of surfactant combinations and development of a novel nanoemulsion for minimising variations in bioavailability of ezetimibe. , 2010, Colloids and surfaces. B, Biointerfaces.

[43]  Y. Byun,et al.  Strategies for oral delivery of macromolecule drugs , 2010 .

[44]  Min Zhang,et al.  Co-delivery of doxorubicin and Bcl-2 siRNA by mesoporous silica nanoparticles enhances the efficacy of chemotherapy in multidrug-resistant cancer cells. , 2009, Small.

[45]  C. Herrenknecht,et al.  Development and validation of an improved liquid chromatography-mass spectrometry method for the determination of pemetrexed in human plasma. , 2009, Journal of chromatography. B, Analytical technologies in the biomedical and life sciences.

[46]  S. Kuo,et al.  Quercetin-induced apoptosis acts through mitochondrial- and caspase-3-dependent pathways in human breast cancer MDA-MB-231 cells , 2009, Human & experimental toxicology.

[47]  Wei Shao,et al.  Formulation optimization and in situ absorption in rat intestinal tract of quercetin-loaded microemulsion. , 2009, Colloids and surfaces. B, Biointerfaces.

[48]  Takuya Suzuki,et al.  Quercetin enhances intestinal barrier function through the assembly of zonula [corrected] occludens-2, occludin, and claudin-1 and the expression of claudin-4 in Caco-2 cells. , 2009, The Journal of nutrition.

[49]  T. Minko,et al.  Co-delivery of siRNA and an anticancer drug for treatment of multidrug-resistant cancer. , 2008, Nanomedicine.

[50]  W. Ahn,et al.  Antiproliferative effects of quercetin through cell cycle arrest and apoptosis in human breast cancer MDA-MB-453 cells , 2008, Archives of pharmacal research.

[51]  C. Apicella,et al.  Bile acids modulate tight junction structure and barrier function of Caco-2 monolayers via EGFR activation. , 2008, American journal of physiology. Gastrointestinal and liver physiology.

[52]  J. Polli,et al.  Apical sodium dependent bile acid transporter (ASBT, SLC10A2): a potential prodrug target. , 2006, Molecular pharmaceutics.

[53]  Xiaoling Fang,et al.  Effect of self-microemulsifying drug delivery systems containing Labrasol on tight junctions in Caco-2 cells. , 2005, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[54]  E. Saez,et al.  Oral chemotherapy: potential benefits and limitations , 2004 .

[55]  S. Hladky,et al.  Interaction of the breast cancer resistance protein with plant polyphenols. , 2004, Biochemical and biophysical research communications.

[56]  A. Adjei.  Pharmacology and mechanism of action of pemetrexed. , 2004, Clinical lung cancer.

[57]  J. Schellens,et al.  Oral bioavailability of docetaxel in combination with OC144-093 (ONT-093) , 2004, Cancer Chemotherapy and Pharmacology.

[58]  P. Paoletti,et al.  Pemetrexed disodium: a novel antifolate clinically active against multiple solid tumors. , 2001, The oncologist.